Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | YH003 |
Trade Name | |
Synonyms | YH-003|YH 003 |
Drug Descriptions |
YH003 is an anti-CD40 agonist antibody that activates CD40 signaling, which may lead to enhanced anti-tumor immune response (J Clin Oncol 39, no. 15_suppl (May 20, 2021) 2580-2580). |
DrugClasses | CD40 Antibody 14 |
CAS Registry Number | NA |
NCIT ID | C178347 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gemcitabine + Nab-paclitaxel + Toripalimab-tpzi + YH003 | Gemcitabine Nab-paclitaxel Toripalimab-tpzi YH003 | 0 | 1 |
Pembrolizumab + YH001 + YH003 | Pembrolizumab YH001 YH003 | 0 | 1 |
Toripalimab-tpzi + YH003 | Toripalimab-tpzi YH003 | 0 | 1 |
YH003 | YH003 | 0 | 0 |